U.S. hospitals, weighing high demand and tight supplies, said they may limit use of a new Eli Lilly and Co antibody drug to COVID-19 patients with multiple risk factors for serious illness or to those ...

The U.S. National Institutes of Health (NIH) said on Tuesday it has started a study to evaluate two antibody treatments in COVID-19 patients as part of the agency's program to identify promising drugs ...

Pending the European Commission’s final decision, nipocalimab could be the first FcRn blocker approved in both adult and adolescent gMG patients aged 12 and older who are anti-AChR or anti-MuSK ...

According to the Indian Council of Medical Research (ICMR), respiratory and food allergies have increased significantly over ...

Here's three main ways to type your blood: One of the easiest and most effective ways to determine your blood type is to have your doctor perform a test. A professional will draw blood and then ...

Can you escape your genetic inheritance, and do lifestyle changes actually make a difference? Daniel Cossins set out to ...

Researchers at the First Affiliated Hospital of the University of Science and Technology of China claim that an in vivo CD8 T ...

From diagnosis to the brutal treatment process, here's what veterinary professionals wish every dog owner understood about ...

Catalent’s preclinical study results provide proof-of-concept support for leveraging certepetide-related biology through its use as an ADC payload ...

Tim Friede's brave decision to inject himself with snake venom may be a gamechanger for creating a universal antivenom.

White-tailed deer host these brain worms, but they don’t actually get the disease, which makes it harder for biologists to ...